DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects

Information source: UCB
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Rhinitis, Allergic, Seasonal

Intervention: levocetirizine dihydrochloride (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: UCB

Official(s) and/or principal investigator(s):
Marie-Etienne Pinelli, MD, Study Director, Affiliation: UCB

Summary

Controlled conditions of the EEU allow a reliable assessment of the efficacy and a determination of the action onset, action intensity and duration of effect of levocetirizine and cetirizine in order to establish the relative efficacy of these two drugs available for the treatment of SAR.

Clinical Details

Official title: Trial to Compare the Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects Exposed to Pollen Challenge in an Environmental Exposure Unit (EEU).

Study design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment

Primary outcome: Mean change from baseline in major symptom complex score over Period 2 (21-29 hours after drug intake on Day 2).

Secondary outcome: Mean change from baseline in MSC score over each 2-hour interval.

Eligibility

Minimum age: 16 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Male/Female, aged >= 16 years

- seasonal allergic rhinitis that required pharmacologic therapy each year during the

last 2 ragweed pollen seasons

- documented seasonal allergy to ragweed pollen

- total symptom score of at least 18 points.

Exclusion Criteria:

- nasal anatomic deformities ? 50% obstruction

- acute sinusitus within 30 days of Period 2

- initiatedor advanced an immunotherapy regimen

- immunotherapy injections within 48 hours of pollen exposure

- impaired hepatic function

- history of malignancy

- intolerance to histamines

- astma requiring medication more than occasional

Locations and Contacts

Additional Information

Starting date: April 2004
Ending date: July 2004
Last updated: March 6, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009